DOKUMEDS expands its operations further by initiating project in 10 Western European countries.

1 Jun, 2017

DOKUMEDS expands its operations further by initiating projects in 10 countries.

New operations in UK, Belgium, Netherlands, Germany, Spain, Italy, Copenhagen, Sweden and Finland.

RIGA, 01 June, 2017 – Leading Latvian contract research organization (CRO), Dokumeds has initiated an observational study and with it further expands its operational footprint throughout Europe.

Dokumeds CEO, Dr. Indra Aboltina said: “Dokumeds extending its operations to Western Europe has been achieved by targeted investments in the processes and structure ensuring flexibility in project resourcing”.

With the expansion, Dokumeds now has a larger footprint in the clinical trial landscape in Europe. With offices in Latvia, Lithuania, Estonia, Poland, Romania, Bulgaria, Ukraine and two in Russia, Dokumeds has the operational capacity to manage various clinical stage projects throughout Europe. Maris Veldre, Director of Clinical Operations said: “It is a challenge to our company’s management, ensuring effective project start-up in new countries with specific regulatory environment.

ABOUT DOKUMEDS Dokumeds is a 20+ year old company headquartered in Riga, Latvia that has provided a full range of clinical research services to more than 270 sponsor companies. With offices in 9 countries, Dokumeds is able to manage large, global projects with high quality and minimal risks.